Land: Irland
Sprache: Englisch
Quelle: HPRA (Health Products Regulatory Authority)
MICONAZOLE NITRATE, PREDNISOLONE ACETATE, POLYMYXIN B SULFATE
Richter Pharma AG
QS02CA01
MICONAZOLE NITRATE, PREDNISOLONE ACETATE, POLYMYXIN B SULFATE
23.0/5.0/0
Ear Drops Suspension
POM
Canine, Feline
Prednisolone and antiinfectives
Antibacterial
Authorised
2015-03-13
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Aurimic ear drops and cutaneous suspension for dogs and cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCES: Miconazole nitrate 23.0 mg (equivalent to 19.98 mg miconazole) Prednisolone acetate 5.0 mg (equivalent to 4.48 mg prednisolone) Polymyxin B sulfate 0.5293 mg (equivalent to 5500 IU polymyxin B sulfate) EXCIPIENTS: For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Ear drops and cutaneous suspension. White suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 14/06/2016_ _CRN 7023647_ _page number: 1_ 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of otitis externa and small localised superficial skin infections in dogs and cats caused by infections with the following miconazole and polymyxin B sensitive bacteria and fungi: Gram-positive bacteria – _Staphylococcus _spp. – _Streptococcus _spp. Gram-negative bacteria – _Pseudomonas _spp. – _Escherichia coli_ Yeasts and fungi – _Malassezia pachydermatis_ – _Candida _spp. – _Microsporum _spp. – _Trichophyton _spp. Treatment of _Otodectes cynotis _infestations where there is concurrent infection with miconazole and polymyxin B sensitive pathogens. 4.3 CONTRAINDICATIONS Do not use: - in case of hypersensitivity to the active substances of the veterinary medicinal product, as well as to other corticosteroids, to other azole antifungal agents, or to the excipients - in animals with perforated ear drums - in animals, where resistance of causative agents to polymyxin B and/or miconazole is known - on the mammary glands of lacta Lesen Sie das vollständige Dokument